CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tepnel Life Sciences PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tepnel Life Sciences PLC
Heron House
Crewe Road, Oaks Business Park
Phone: (161) 946-2200p:161 946-2200 Manchester, ENG  M23 9HZ  United Kingdom Ticker: TED TED

This company is no longer actively traded on any major stock exchange.

Business Summary
Tepnel Life Sciences PLC is a United Kingdom-based international life sciences products and services company. It is engaged in the research, development and commercialization of a range of products and services within the life sciences, pharmaceutical and food safety industries. The Company operates in two segments. The research products and services (RPS) segment provides products and services for the biomedical research industry. This includes outsourcing services for pharmaceutical, biotechnology and healthcare industries, food testing products and services and immunological reagents. The molecular diagnostics (MD) segment provides diagnostic testing products and services. These include organ transplant monitoring and human leukocyte antigen (HLA) typing, as well as foetal distress diagnosis and genetic predisposition testing. In April 2009, Gen-Probe Incorporated completed the acquisition of Tepnel Life Sciences PLC.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/200812/31/2008Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non Executive Chairman of the Board, Company Secretary I. AlecCraig 5/1/2003
Chief Executive, Director BenjaminMatzilevich 1/1/2001
Finance Director, Executive Director Michael K.Slater 1/24/2008 1/24/2008
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 215 (As of 12/31/2007)
Outstanding Shares: 249,716,693 (As of 4/2/2009)
Shareholders: 3,278
Stock Exchange: SEA
Fax Number: (161) 946-2211


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023